D.E. Shaw & Co
RCPI

D.E. Shaw & Co’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

D.E. Shaw & Co’s Portfolio RCPI Stock Details RCPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-2,071
Closed -$31K – 4650
2014
Q2 		$31K Buy
+2,071
New +$35.9K ﹤0.01% 4123

Other funds holding RCPI

GCM
Goldman Capital Management New York $103M AUM 21.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TC
Talkot Capital Sausalito, California $73.7M AUM 8.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KCM
Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return

D.E. Shaw & Co's RCPI Position: Q3 2014 in Review

D.E. Shaw & Co sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q3 2014, closing a stake of 2,071 shares — an estimated $31K sold.

D.E. Shaw & Co first reported a position in RCPI in Q2 2014 and held it in 1 quarter. The position peaked at $31K in Q2 2014. 67 funds tracked by Wall St. Rank hold RCPI as of Q3 2014.

  • D.E. Shaw & Co reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • D.E. Shaw & Co sold 2,071 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $31K.
  • D.E. Shaw & Co first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 1 quarter.
  • D.E. Shaw & Co's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $31K in Q2 2014.
  • 67 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on D.E. Shaw & Co's 13F filing for Q3 2014, filed 14 Nov 2014.